Division of Hospital Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Hosp Med. 2019 Aug;14(8):474-481. doi: 10.12788/jhm.3222.
While medical complexity is associated with pediatric readmission risk, less is known about how increases in medical complexity during hospitalization affect readmission risk.
We conducted a five-year retrospective, case-control study of pediatric hospitalizations at a tertiary care children's hospital. Cases with a 30-day unplanned readmission were matched to controls based on admission seasonality and distance from the hospital. Complexity variables included the number of medications prescribed at discharge, medical technology, and the need for home healthcare services. Change in medical complexity variables included new complex chronic conditions and new medical technology. We estimated odds of 30-day unplanned readmission using adjusted conditional logistic regression.
Of 41,422 eligible index hospitalizations, we included 595 case and 595 control hospitalizations. Complexity: Polypharmacy after discharge was common. In adjusted analyses, being discharged with ≥2 medications was associated with higher odds of readmission compared with being discharged without medication; children with ≥5 discharge medications had a greater than four-fold higher odds of readmission. Children assisted by technology had higher odds of readmission compared with children without technology assistance. Change in complexity: New diagnosis of a complex chronic condition (Adjusted Odds Ratio (AOR) = 1.75; 1.11-2.75) and new technology (AOR = 1.84; 1.09-3.10) were associated with higher risk of readmission when adjusting for patient characteristics. However, these associations were not statistically significant when adjusting for length of stay.
Polypharmacy and use of technology at discharge pose a substantial readmission risk for children. However, added technology and new complex chronic conditions do not increase risk when accounting for length of stay.
虽然医疗复杂性与儿科再入院风险相关,但住院期间医疗复杂性增加如何影响再入院风险知之甚少。
我们对一家三级儿童保健医院的儿科住院患者进行了一项为期五年的回顾性病例对照研究。根据入院季节性和与医院的距离,将 30 天内计划外再入院的病例与对照相匹配。复杂性变量包括出院时开具的药物数量、医疗技术和家庭保健服务需求。复杂性变量的变化包括新的复杂慢性病和新的医疗技术。我们使用调整后的条件逻辑回归估计 30 天内计划外再入院的可能性。
在 41422 例合格的索引住院中,我们纳入了 595 例病例和 595 例对照住院。复杂性:出院后使用多种药物很常见。在调整分析中,与未服用药物出院相比,出院时服用≥2 种药物与更高的再入院几率相关;出院时服用≥5 种药物的儿童再入院几率高出四倍以上。使用技术辅助的儿童与未使用技术辅助的儿童相比,再入院的几率更高。复杂性的变化:新诊断出复杂慢性病(调整后的优势比(AOR)=1.75;1.11-2.75)和新的技术(AOR=1.84;1.09-3.10)与调整患者特征后的再入院风险增加相关。然而,当调整住院时间时,这些关联并不具有统计学意义。
出院时的多种药物治疗和使用技术会给儿童带来很大的再入院风险。然而,当考虑住院时间时,增加的技术和新的复杂慢性病并不会增加风险。